Page 70 - DP Vol 21 No1_Neat

EXCLUSIVE INTERVIEW

A CONVERSATION WITH DR. ANDREAS GEISTLICH

ON GEISTLICH PHARMA’S VISION FOR INDIA

AND BEYOND

Geistlich Pharma has long been synonymous with excellence in regenerative dentistry. Headquartered in Wolhusen, Switzerland,
the company is renowned globally for its biomaterials that have redefined tissue regeneration and clinical outcomes in dental
practices. As India continues to emerge as a pivotal market in the global dental landscape, Geistlich has steadily deepened its
footprint — not just by offering cutting-edge products, but by fostering education, clinical training, and scientific advancement. In
this exclusive conversation, Dr. Utkarshaa Jaiswal from MediMedia India speaks with Dr. Andreas Geistlich, the Chairman of Geistlich
Pharma, during his visit to India after six years. From market insights and innovation strategies to upcoming product launches and
the role of global foundations, Dr. Geistlich offers a comprehensive view of how the company is shaping the future of regenerative
dentistry in India and beyond.

MediMedia: You are visiting India after six years. What significant Geistlich India has evolved considerably since my last visit.
changes have you observed during this time? The team has expanded with new hires, and they have now started
educating practitioners in soft tissue management. Additionally, we
Dr. Geistlich: My last visit to India was in 2019, just before COVID-19. have increased our network of Key Opinion Leaders (KOLs) and are
From afar, I observed that India managed the COVID crisis quite well steadily building connections day by day. Overall, this has been a very
— so congratulations for that. Since the pandemic has ended, the exciting and dynamic development.
country has established itself firmly as an emerging market, consistently
increasing its GDP year by year and demonstrating a solid growth rate. MediMedia: Geistlich Pharma India has now been in existence for
This growth is also reflected in your market. The size of the middle over 8 years. In what ways do you feel the Indian market is different
class is increasing, and naturally, so are the number of people who can from the other markets you operate in?
afford and who demand our treatments. This creates a very interesting
development environment for Geistlich. Dr. Geistlich: I would say India is still an emerging market — but

70 Dental Practice I March-April 2025 I Vol 21 No 2